Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid β toxicity in Alzheimer's disease

FEBS Journal

Volumn 276, Issue 10, 2009, Pages 2736-2751

  Shaked, Gideon M ^a   Chauv, Stephanie ^a   Ubhi, Kiren ^a   Hansen, Lawrence A ^a,b   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caspase; Endoplasmic reticulum; Neurodegeneration; Voltage gated calcium channels

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM; GO PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; RAT; SAMPLE; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; CALCIUM; CELLS, CULTURED; GTP-BINDING PROTEINS; HUMANS;

EID: 65349144513     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06997.x     Document Type: Article

References (63)

1. Dickson DW (2001) Neuropathology of Alzheimer's disease and other dementias. Clin Geriatr Med 17, 209 228. (Pubitemid 32429328)
2. Mehta PD (2007) Amyloid beta protein as a marker or risk factor of Alzheimer's disease. Curr Alzheimer Res 4, 359 363. (Pubitemid 47416628)
3. Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B Yankner BA (2000) Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci 3, 460 464. (Pubitemid 30495627)
4. Lu DC, Soriano S, Bredesen DE Koo EH (2003) Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity. J Neurochem 87, 733 741. (Pubitemid 37310638)
5. Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE Koo EH (2006) Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J 20, 1254 1256.
6. Sola Vigo F, Kedikian G, Heredia L, Heredia F, Anel AD, Rosa AL Lorenzo A (2008) Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation. Neurobiol Aging doi : (in press).
7. Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Murayama Y Ogata E (1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362, 75 79. (Pubitemid 23087295)
8. Swanson TL, Knittel LM, Coate TM, Farley SM, Snyder MA Copenhaver PF (2005) The insect homologue of the amyloid precursor protein interacts with the heterotrimeric G protein Go alpha in an identified population of migratory neurons. Dev Biol 288, 160 178. (Pubitemid 41713161)
9. Birnbaumer L (1990) G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30, 675 705. (Pubitemid 20139560)
10. 2+ channels. J Recept Signal Transduct Res 25, 57 71. (Pubitemid 41209260)
11. Hille B (1992) G protein-coupled mechanisms and nervous signaling. Neuron 9, 187 195.
12. Hille B (1994) Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci 17, 531 536. (Pubitemid 124000831)
13. 2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits. Proc Natl Acad Sci USA 98, 4699 4704. (Pubitemid 32295039)
14. Weiss N De Waard M (2006) Introducing an alternative biophysical method to analyze direct G protein regulation of voltage-dependent calcium channels. J Neurosci Methods 160, 26 36.
15. Garcia-Jimenez A, Cowburn RF, Ohm TG, Lasn H, Winblad B, Bogdanovic N Fastbom J (2002) Loss of stimulatory effect of guanosine triphosphate on (35)SGTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield. J Neurosci Res 67, 388 398. (Pubitemid 34137146)
16. Cowburn RF, O'Neill C, Bonkale WL, Ohm TG Fastbom J (2001) Receptor-G-protein signalling in Alzheimer's disease. Biochem Soc Symp 67, 163 175. (Pubitemid 33602684)
17. O'Neill C, Wiehager B, Fowler CJ, Ravid R, Winblad B Cowburn RF (1994) Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain. Brain Res 636, 193 201. (Pubitemid 24044635)
18. O'Neill C, Cowburn RF, Bonkale WL, Ohm TG, Fastbom J, Carmody M Kelliher M (2001) Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 67, 177 194. (Pubitemid 33602685)
19. Green KN, Smith IF Laferla FM (2007) Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. Subcell Biochem 45, 507 521.
20. Bojarski L, Herms J Kuznicki J (2008) Calcium dysregulation in Alzheimer's disease. Neurochem Int 52, 621 633. (Pubitemid 36916950)
21. Brouillet E, Trembleau A, Galanaud D, Volovitch M, Bouillot C, Valenza C, Prochiantz A Allinquant B (1999) The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. J Neurosci 19, 1717 1727. (Pubitemid 29094190)
22. Rymer DL Good TA (2001) The role of G protein activation in the toxicity of amyloidogenic Abeta-(1-40), Abeta-(25-35), and bovine calcitonin. J Biol Chem 276, 2523 2530. (Pubitemid 33649104)
23. Hescheler J, Rosenthal W, Trautwein W Schultz G (1987) The GTP-binding protein, Go, regulates neuronal calcium channels. Nature 325, 445 447. (Pubitemid 17056412)
24. Schultz G, Rosenthal W, Hescheler J Trautwein W (1990) Role of G proteins in calcium channel modulation. Annu Rev Physiol 52, 275 292. (Pubitemid 20103538)
25. Zhao M, Su J, Head E Cotman CW (2003) Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol Dis 14, 391 403. (Pubitemid 37543518)
26. Borg JP, Ooi J, Levy E Margolis B (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16, 6229 6241. (Pubitemid 26360983)
27. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH et al. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 17, 1951 1953.
28. Matsuda S, Yasukawa T, Homma Y, Ito Y, Niikura T, Hiraki T, Hirai S, Ohno S, Kita Y, Kawasumi M et al. (2001) c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J Neurosci 21, 6597 6607. (Pubitemid 32781104)
29. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K et al. (2006) Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103, 7130 7135.
30. Bredesen DE Rabizadeh S (2007) APP-based neuroprotective strategies. Curr Alzheimer Res 4, 541 543. (Pubitemid 350248386)
31. Arispe N, Pollard HB Rojas E (1994) Beta-amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Mol Cell Biochem 140, 119 125.
32. Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH Heinemann SF (2006) Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci 26, 13428 13436. (Pubitemid 46026474)
33. Jansson CC, Kukkonen JP, Nasman J, Huifang G, Wurster S, Virtanen R, Savola JM, Cockcroft V Akerman KE (1998) Protean agonism at alpha2A- adrenoceptors. Mol Pharmacol 53, 963 968.
34. Lumbreras M, Baamonde C, Martinez-Cue C, Lubec G, Cairns N, Salles J, Dierssen M Florez J (2006) Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease. Amino Acids 31, 449 456.
35. Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G Aliev G (2006) Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res 10, 43 56.
36. Reis K, Zharkovsky A, Bogdanovic N, Karelson E Land T (2007) Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723). Neuroscience 144, 571 578.
37. Kim HS, Park CH, Cha SH, Lee JH, Lee S, Kim Y, Rah JC, Jeong SJ Suh YH (2000) Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J 14, 1508 1517. (Pubitemid 30639070)
38. Stutzmann GE (2005) Calcium dysregulation, IP3 signaling, and Alzheimer's disease. Neuroscientist 11, 110 115. (Pubitemid 40388493)
39. Khachaturian ZS (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Ann NY Acad Sci 747, 1 11.
40. Etcheberrigaray R, Hirashima N, Nee L, Prince J, Govoni S, Racchi M, Tanzi RE Alkon DL (1998) Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis 5, 37 45. (Pubitemid 28361650)
41. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl Acad Sci USA 91, 534 538. (Pubitemid 2042532)
42. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC, Jannatipour M, Anliker B, Muller U, Saftig P, De Strooper B et al. (2002) A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. Proc Natl Acad Sci USA 99, 4697 4702. (Pubitemid 34286047)
43. Demuro A, Mina E, Kayed R, Milton SC, Parker I Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294 17300. (Pubitemid 41389198)
44. Sokolov Y, Kozak JA, Kayed R, Chanturiya A, Glabe C Hall JE (2006) Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol 128, 637 647.
45. Goodman Y Mattson MP (1994) Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128, 1 12. (Pubitemid 24278360)
46. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16, 409 414. (Pubitemid 23283402)
47. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I Rydel RE (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12, 376 389.
48. Pierrot N, Ghisdal P, Caumont AS Octave JN (2004) Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem 88, 1140 1150. (Pubitemid 38280681)
49. Pierrot N, Santos SF, Feyt C, Morel M, Brion JP Octave JN (2006) Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. J Biol Chem 281, 39907 39914. (Pubitemid 46041794)
50. Querfurth HW Selkoe DJ (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33, 4550 4561. (Pubitemid 24145103)
51. Resende R, Ferreiro E, Pereira C Resende de Oliveira C (2008) Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155, 725 737.
52. Arispe N, Pollard HB Rojas E (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein A beta P-(1-40) in bilayer membranes. Proc Natl Acad Sci USA 90, 10573 10577. (Pubitemid 23347084)
53. Kagan BL, Azimov R Azimova R (2004) Amyloid peptide channels. J Membr Biol 202, 1 10. (Pubitemid 40298660)
54. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA Butterfield DA (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91, 3270 3274. (Pubitemid 24130218)
55. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron. J Neurosci Res 50, 522 530. (Pubitemid 27510035)
56. Digby GJ, Lober RM, Sethi PR Lambert NA (2006) Some G protein heterotrimers physically dissociate in living cells. Proc Natl Acad Sci USA 103, 17789 17794.
57. Digby GJ, Sethi PR Lambert NA (2008) Differential dissociation of G protein heterotrimers. J Physiol 586, 3325 3335.
58. Abdulaev NG, Ngo T, Zhang C, Dinh A, Brabazon DM, Ridge KD Marino JP (2005) Heterotrimeric G-protein alpha-subunit adopts a 'preactivated' conformation when associated with betagamma-subunits. J Biol Chem 280, 38071 38080. (Pubitemid 41642421)
59. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A Saitoh T (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467 475.
60. Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H Masliah E (2006) Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J Neurosci Res 83, 1252 1261. (Pubitemid 43668008)
61. Ueda H, Morishita R, Katoh-Semba R, Kato K Asano T (1998) G protein gamma subunits coimmunoprecipitated with antibodies against alpha subunits: identification of major isoforms in cultured cells by silver stain and immunoblotting with conventional transfer procedure. J Biochem 124, 1033 1037. (Pubitemid 28544917)
62. Xu X, Yang D, Wyss-Coray T, Yan J, Gan L, Sun Y Mucke L (1999) Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc Natl Acad Sci USA 96, 7547 7552. (Pubitemid 29299699)
63. Takenouchi T, Hashimoto M, Hsu LJ, Mackowski B, Rockenstein E, Mallory M Masliah E (2001) Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein. Mol Cell Neurosci 17, 141 150. (Pubitemid 32113544)